CLOSE X
Mutual Fund
more from Mutual Fund
HomeMarketsMutual Fund MF UpdatesFund Card

Fund Card

GO

HDFC Pharma and Healthcare Fund-Reg(G)

very highequitypharma & health care
17.34 -0.04(-0.26%) NAV as on 23 Dec 2025
0.2 % 1 M
5.67 % 1 Y
NA 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.09

As on 30 Nov, 2025
age-icon Age :

2 yrs 2 m

Since 04 10 ,2023
exit_load Exit Load :

1%

aum AUM :

2,010.77 Crs

lock_in Lock-in :

1% on or before 30D, Nil after 30D

investing_style Investing Style :

Mid Growth

Portfolio_book_value Portfolio Price To Book Value :

8.57

Min_Investment Min. Investment :

SIP 100 & Lumpsum 100

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Nikhil Mathur

LATEST ASSET & PORTFOLIO ALLOCATION

as on Nov 30 ,2025
Others 1.62 %
Equity 98.38 %

TOP HOLDINGS

Sun Pharmaceutical Industries...11.34 %
Divi's Laboratories Ltd.8.34 %
Lupin Ltd.6.40 %
Glenmark Pharmaceuticals Ltd.6.09 %
Max Healthcare Institute Ltd.6.07 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs74.17
Hospital & Healthcare Services22.29
Miscellaneous1.03
Medical Equipment/Supplies/Accessories0.89
See All Sectors

5-YEARS HISTORY

Financial Year2023-20242024-2025
NAV in Rs (as on 31-Mar-2025)12.2915.92
Net Assets(Rs Crores) (as on 31-Mar-2025) 800.65 1634.08
Scheme Returns(%)(Absolute)23.3028.35
B'mark Returns(%)(Absolute)NANA
Category Rank66/901/102

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

HDFC Pharma and Healthcare Fund-Reg(G)Very HighEquity17.34-0.04(-0.26%)NAV As on 23 Dec, 202504-Oct-2023Inception Date2,010.77AUM In Cr.5.67%1YNA%3YNA%5Y28.50%Since Inception
UTI Healthcare Fund-Reg(G)Very HighEquity286.42-0.76(-0.27%)NAV As on 23 Dec, 202501-Aug-2005Inception Date1,126.13AUM In Cr.0.28%1Y23.88%3Y15.67%5Y17.89%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity30.360.17(0.55%)NAV As on 23 Dec, 202528-Dec-2015Inception Date1,338.85AUM In Cr.-1.47%1Y21.45%3Y15.59%5Y11.76%Since Inception
corporate OFFICE Jhaveri Securities301/302 Payal Tower-II,Opp. M. S. University, Sayajigunj, Vadodara 390020.
CALL US 91-265-6161200/7161200
EMAIL US info@jhaveritrade.com
SEBI Reg. No. NSE, BSE, MCX : INZ000199232 Membership No.: NSE:08232, BSE:3015, MCX:56465 SEBI Regn.No. of DP : IN-DP-195-2016 (NSDL DPID:IN301991) AMFI: ARN-A3524 CIN of JSL: U67120GJ1992PLC018194 | GST : 24AAACJ4727A2Z4
COMPLIANCE OFFICER OFFICE
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors
© CopyRights 2022, Jhaveri Securities All rights reserved.
Designed & Developed by Accord Fintech Pvt Ltd.